SHEBA MEDICAL CENTER

🇿🇦South Africa

Country: 🇿🇦South Africa

Ownership: Private

Established: 1948-01-01

Employees: 10K

Market Cap: -

Website: http://www.sheba.co.il

Clinical Trials

Mother to Newborn Transmission of Staphylococcus Aureus and Dynamics of S.Aureus Carriage During the First Years Life

Conditions: Staphylococcus Aureus

First Posted Date: 2017-02-27

Last Posted Date: 2017-02-27

Lead Sponsor: Sheba Medical Center

Target Recruit Count: 600

Registration Number: NCT03064373

Locations: 🇮🇱
Sheba Medical Center, Ramat-Gan, Israel

Open Label Trial of Triheptanoin (UX007) in Treatment of Rett Syndrome.

Phase 2

Conditions: Rett Syndrome

Interventions: Drug: Tridecanoic Acid

First Posted Date: 2017-02-23

Last Posted Date: 2017-02-23

Lead Sponsor: Sheba Medical Center

Target Recruit Count: 10

Registration Number: NCT03059160

The Effect of Alpha Linolenic Acid (ALA) Supplementation During Pregnancy

Not Applicable

Withdrawn

Conditions: Omega 3 Supplements During Pregnancy

Interventions: Dietary Supplement: Omega 3 enriched diet ( DHA+EPA)
Other: Placebo
Dietary Supplement: Alpha Linolenic Acid

First Posted Date: 2017-02-02

Last Posted Date: 2022-04-14

Lead Sponsor: Sheba Medical Center

Registration Number: NCT03040856

Locations: 🇮🇱
Dr. A Mohr-Sasson, Ramat-Gan, Israel

Manual Fascial Manipulation in Pregnant Women

Not Applicable

Completed

Conditions: Pelvic Floor Disorders

Interventions: Procedure: Pelvic floor fascial mobilization

First Posted Date: 2017-02-02

Last Posted Date: 2020-06-09

Lead Sponsor: Sheba Medical Center

Target Recruit Count: 80

Registration Number: NCT03041246

Locations: 🇮🇱
Sheba Medical Center, Ramat Gan, Israel

MR Imaging Study of TBI in Children

Recruiting

Conditions: TBI (Traumatic Brain Injury)

First Posted Date: 2017-01-27

Last Posted Date: 2023-11-24

Lead Sponsor: Sheba Medical Center

Target Recruit Count: 60

Registration Number: NCT03034031

Locations: 🇮🇱
Sheba medical center Tel Hashomer, Ramat Gan, Israel

Chewing Ticagrelor Versus Prasugrel in ST-elevation Myocardial Infarction - A Platelet Reactivity Study

Phase 4

Conditions: Acute Coronary Syndrome
STEMI

Interventions: Drug: Chewing Prasugrel LD
Drug: Chewing Ticagrelor LD

First Posted Date: 2017-01-10

Last Posted Date: 2017-01-10

Lead Sponsor: Sheba Medical Center

Target Recruit Count: 100

Registration Number: NCT03016611

Locations: 🇮🇱
Sheba Medical center, Ramat Gan, Israel

Role of Oxytocin in Myocardial Infarction

Phase 2

Conditions: Myocardial Infarction

Interventions: Drug: Placebos
Drug: Oxytocin

First Posted Date: 2016-12-23

Last Posted Date: 2016-12-23

Lead Sponsor: Sheba Medical Center

Target Recruit Count: 52

Registration Number: NCT03001635

Androgenic Profile Following Controlled Ovarian Stimulation

Phase 4

Conditions: Infertility, Female

Interventions: Drug: recombinant gonadotropins
Drug: HP-HMG

First Posted Date: 2016-12-14

Last Posted Date: 2016-12-20

Lead Sponsor: Sheba Medical Center

Target Recruit Count: 100

Registration Number: NCT02992808

Phase 3 Multicenter Randomized Double Blind Placebo Controlled Study With Antibacterial Prophylaxis in Azacitidine Treated MDS Patients

Phase 3

Completed

Conditions: Prevention

Interventions: Drug: Levofloxacin
Drug: Placebo Oral Tablet

First Posted Date: 2016-12-05

Last Posted Date: 2023-11-27

Lead Sponsor: Sheba Medical Center

Target Recruit Count: 67

Registration Number: NCT02981615

Locations: 🇮🇱
Chim Sheba Medical Center, Tel Hashomer, Israel

Safety and Efficacy of Carbone Dioxide (CO2) Laser System in Treatment of Female Stress Urinary Incontinence.

Not Applicable

Conditions: Female Stress Urinary Incontinence

Interventions: Device: Alma Lasers Pixel carbon dioxide laser system

First Posted Date: 2016-12-05

Last Posted Date: 2016-12-06

Lead Sponsor: Sheba Medical Center

Target Recruit Count: 60

Registration Number: NCT02981654

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy